HCID 86720237, compound → HCID 86720236, compound
Reaction equation
[C:1]([O:20][C@:21]1([C@:42]2([CH3:43])[C@H:28]([C@H:29]3[C:39](=[CH:40][CH2:41]2)[C@:37]2([CH3:38])[C:32](=[CH:33][C:34](=[O:44])[CH2:35][CH2:36]2)[CH2:31][CH2:30]3)[CH2:27][CH2:26]1)[C:22](=[O:25])[CH2:23][OH:24])(=[O:19])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH2:12][CH2:13][CH2:14][CH2:15][CH2:16][CH2:17][CH3:18]>C(OC(=O)CCC)(=O)CCC.[Cl-].C([N+](CCCC)(CCCC)C)CCC>[C:1]([O:20][C@:21]1([C@:42]2([CH3:43])[C@H:28]([C@H:29]3[C:39](=[CH:40][CH2:41]2)[C@:37]2([CH3:38])[C:32](=[CH:33][C:34](=[O:44])[CH2:35][CH2:36]2)[CH2:31][CH2:30]3)[CH2:27][CH2:26]1)[C:22](=[O:25])[CH2:23][O:24][C:1](=[O:19])[CH2:2][CH2:3][CH3:4])(=[O:19])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH2:12][CH2:13][CH2:14][CH2:15][CH2:16][CH2:17][CH3:18]Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
the residue (6.2 g) of 17α-octadecanoyloxy-21-hydroxy-pregna-4,9(11)-diene-3,20-dione was dissolved in 4 ml butyric anhydride in the presence of 0.5 g of tributylmethylammonium chloride. The mixture was stirred at room temperature for 2 hours, then poured in ice and the resulting product was separated from water by extraction. The extract was washed to neutrality with water and concentrated under vacuum, the residue was crystallized from methanol to obtain 5.5 g (8.05 mM) of 17α-octadecanoyloxy-21-butanoyloxy-pregna-4,9(11)-diene-3,20-dione. This compound was used for the preparation of a pharmaceutical formulation in the form of a cream suitable for cutaneous administration.
Workup
- additionpoured in ice
- customthe resulting product was separated from water by extraction
- washThe extract was washed
- concentrationconcentrated under vacuum
- customthe residue was crystallized from methanol
Sources & evidence
- ORD record
- ord-2769bea14d2c4efc8c2fc13505172da5
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09211295B2
Reaction notes
Loading…